Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sydney L Payne

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Medical Systems|May 6, 2022
The Flexible Care Pathway: An Alternative Paradigm for Post-Operative CareSydney L Payne, Lyly Nguyen, Ashkan Afshari, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2014
Letrozole vs anastrozole for height augmentation in short pubertal males: first year dataE Kirk Neely, Rajiv B Kumar, Sydney L Payne, et al.
Journal of Diabetes Science and Technology|September 19, 2014
The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetesMatthew Stenerson, Fraser Cameron, Shelby R Payne, et al.
Diabetes Technology & Therapeutics|May 27, 2016
Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 DiabetesAndrew W Karlin, Trang T Ly, Laura Pyle, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Medical Systems|May 6, 2022
The Flexible Care Pathway: An Alternative Paradigm for Post-Operative CareSydney L Payne, Lyly Nguyen, Ashkan Afshari, et al.
The Journal of Clinical Endocrinology and Metabolism|August 20, 2014
Letrozole vs anastrozole for height augmentation in short pubertal males: first year dataE Kirk Neely, Rajiv B Kumar, Sydney L Payne, et al.
Journal of Diabetes Science and Technology|September 19, 2014
The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetesMatthew Stenerson, Fraser Cameron, Shelby R Payne, et al.
Diabetes Technology & Therapeutics|May 27, 2016
Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 DiabetesAndrew W Karlin, Trang T Ly, Laura Pyle, et al.
Pageof 1